Congrès 3CVD de Chirurgie Générale

15 au 18 septembre 2026 – CNIT FOREST – PARIS
Webinar FEMTECH SCGP

Comment aller plus loin en chirurgie mini-invasive pelvienne ? (Pr Céline CHAULEUR)
Moderation SCGP Bordeaux 2026

23e journées de Chirurgie Gynécologique et Pelvienne – 16, 17 & 18 septembre 2026
MedinTECH Paris

Intelligence Artificielle Robotique & Chirurgie de précision – Mars 2026
Single-port robot-assisted vaginal natural orifice transluminal endoscopic surgery hysterectomy and bilateral adnexectomy with retroperitoneal sentinel lymph node dissection for endometrial cancer in a morbidly obese patient
Louise Monioda, Aslam Mansoorb,Celine Chauleur
Number of Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC) Treatments is Associated with Longer Survival: Analysis of a Large Prospective Cohort of Patients With Unresectable Peritoneal Surface Malignancies
Ran Orgad 1, Naoual Bakrin 1 2, Isabelle Bonnefoy 2, Laurent Villeneuve 2, Mohamad Alyami 3, Omar Alhadeedi 1 2, Olivier Glehen 1 2, Vahan Kepenekian 1 2
Cytoreductive Surgery With or Without Hyperthermic Intraperitoneal Chemotherapy for Gastric Cancer With Peritoneal Metastases (CYTO-CHIP study): A Propensity Score Analysis
Pierre-Emmanuel Bonnot 1 2, Guillaume Piessen 3, Vahan Kepenekian 1 2, Evelyne Decullier 4, Marc Pocard 5, Bernard Meunier 6, Jean-Marc Bereder 7, Karine Abboud 8, Frédéric Marchal 9, François Quenet 10, Diane Goere 11, Simon Msika 12, Catherine Arvieux 13, Nicolas Pirro 14, Romuald Wernert 15, Patrick Rat 16, Johan Gagnière 17, Jeremie H Lefevre 18, Thomas Courvoisier 19, Reza Kianmanesh 20, Delphine Vaudoyer 1 2, Michel Rivoire 21, Pierre Meeus 21, Guillaume Passot 1 2, Olivier Glehen 1 2; FREGAT and BIG-RENAPE Networks
Pressurised intraperitoneal aerosol chemotherapy: rationale, evidence, and potential indications
Mohammad Alyami 1, Martin Hübner 2, Fabian Grass 3, Naoual Bakrin 4, Laurent Villeneuve 5, Nathalie Laplace 4, Guillaume Passot 4, Olivier Glehen 4, Vahan Kepenekian 4
Cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy versus cytoreductive surgery alone for colorectal peritoneal metastases (PRODIGE 7): a multicentre, randomised, open-label, phase 3 trial
François Quénet 1, Dominique Elias 2, Lise Roca 3, Diane Goéré 2, Laurent Ghouti 4, Marc Pocard 5, Olivier Facy 6, Catherine Arvieux 7, Gérard Lorimier 8, Denis Pezet 9, Frédéric Marchal 10, Valeria Loi 11, Pierre Meeus 12, Beata Juzyna 13, Hélène de Forges 14, Jacques Paineau 15, Olivier Glehen 16; UNICANCER-GI Group and BIG Renape Group
Advances in the management of peritoneal malignancies
Vahan Kepenekian 1 2, Aditi Bhatt 3, Julien Péron 4 5, Mohammad Alyami 6, Nazim Benzerdjeb 2 7, Naoual Bakrin 1 2, Claire Falandry 8, Guillaume Passot 1 2, Pascal Rousset 2 9, Olivier Glehen 10 11
The 2022 PSOGI International Consensus on HIPEC Regimens for Peritoneal Malignancies: HIPEC Technologies
Kurt Van der Speeten # 1 2, Shigeki Kusamura # 3, Laurent Villeneuve 4, Pompiliu Piso 5, Vic J Verwaal 6, Santiago González-Moreno 7, Olivier Glehen 4
Hyperthermic intraperitoneal chemotherapy for recurrent ovarian cancer (CHIPOR): a randomised, open-label, phase 3 trial
Jean-Marc Classe 1, Pierre Meeus 2, Delphine Hudry 3, Romuald Wernert 4, François Quenet 5, Frédéric Marchal 6, Gilles Houvenaeghel 7, Anne-Sophie Bats 8, Fabrice Lecuru 8, Gwenaël Ferron 9, Cécile Brigand 10, Dominique Berton 11, Laurence Gladieff 9, Florence Joly 12, Isabelle Ray-Coquard 2, Sylvaine Durand-Fontanier 13, Gabriel Liberale 14, Marc Pocard 15, Constantin Georgeac 16, Sébastien Gouy 17, Jean-Marc Guilloit 18, Frédéric Guyon 19, Cristina Costan 20, Jean-Marc Rousselet 21, Lara de Guerké 22, Naoual Bakrin 23, Emilie Brument 24, Elodie Martin 11, Bernard Asselain 25, Loïc Campion 26, Olivier Glehen 23; UNICANCER/CHIPOR Investigators